# Serial Endoscopic Surveillance & Direct Topical Antibiotics to Define the Role of Microbes in Anastomotic Healing

> **NCT02682485** · PHASE2 · WITHDRAWN · sponsor: **University of Chicago**

## Conditions studied

- Anastomotic Leak
- Rectal Cancer

## Interventions

- **DRUG:** Cipro, metronidazole, neomycin combo
- **PROCEDURE:** Serial Endoscopic Surveillance
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02682485
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-03-03
- **Primary completion:** 2017-03-03
- **Final completion:** 2017-03-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2023-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02682485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02682485, "Serial Endoscopic Surveillance & Direct Topical Antibiotics to Define the Role of Microbes in Anastomotic Healing". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02682485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
